Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-12

FDA Approved: METOPROLOL SUCCINATE — Original Application (Epic Pharma, LLC)

View source ↗

Summary

FDA approves the original application for metoprolol succinate as a generic extended-release beta-blocker indicated for hypertension and heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metoprolol succinate (METOPROLOL SUCCINATE)

Snippet

ORIG AP for METOPROLOL SUCCINATE (METOPROLOL SUCCINATE)